Group One Trading
DMAC icon

Group One Trading’s DiaMedica Therapeutics DMAC Stock Holding History

Group One Trading’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,342
Closed -$8.25K – 7782
2026
Q1 		$9.09K Sell
1,342
-47
-3% -$372 ﹤0.01% 6419
2025
Q4 		$11.1K Buy
1,389
+1,002
+259% +$7.49K ﹤0.01% 6760
2025
Q3 		$2.66K Buy
387
+266
+220% +$1.44K ﹤0.01% 7814
2025
Q2 		$472 Buy
+121
New +$472 ﹤0.01% 7668
2024
Q1 		– Sell
-4,843
Closed -$14.1K – 7221
2023
Q4 		$13.8K Buy
+4,843
New +$12K ﹤0.01% 5998
2022
Q2 		– Sell
-20
Closed -$47 – 7953
2022
Q1 		$0 Sell
20
-33,848
-100% -$96K ﹤0.01% 8144
2021
Q4 		$126K Buy
33,868
+9,650
+40% +$37.9K ﹤0.01% 5512
2021
Q3 		$97K Buy
24,218
+20,496
+551% +$78.4K ﹤0.01% 5943
2021
Q2 		$17K Buy
+3,722
New +$30.5K ﹤0.01% 7280

Other funds holding DMAC

CLG
Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Group One Trading's DMAC Position: Q2 2026 in Review

Group One Trading sold out of DiaMedica Therapeutics (DMAC) in Q2 2026, closing a stake of 1,342 shares — an estimated $8.25K sold.

Group One Trading first reported a position in DMAC in Q2 2021 and held it in 9 quarters. The position peaked at $126K in Q4 2021. 89 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

  • Group One Trading reported no remaining DiaMedica Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 1,342 DiaMedica Therapeutics shares in Q2 2026, an estimated $8.25K.
  • Group One Trading first reported a position in DiaMedica Therapeutics in Q2 2021 and held it in 9 quarters.
  • Group One Trading's DiaMedica Therapeutics position peaked at $126K in Q4 2021.
  • 89 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.